// App-Quantinova.ai

MON-042 : Fixed Dose Steroids as Part of Immunosuppressive Therapy in Idiopathic Membranous Nephropathy A Single Centre Experience

Researchers

Presenter

  • G. RANA

Principal Investigators

  • T. Sherazee

  • M. El Kossi

Medical Centers

  • Manchester School of Medicine, Nephrology, Doncaster, United Kingdom

  • Doncaster and Bassetlaw Teaching Hospitals NHS Trust, Nephrology, Doncaster, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Nephrology

Disease

  • Membranous glomerulonephritis

  • Albuminuria

Biomarkers

  • Creatinine

  • Cytochrome C

Drug/Treatment

  • Methylprednisolone

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Prednisolone

Outcome

  • N/A


Study Design

  • Fixed Dose

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A